Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William H Ludlam

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Advances in Therapy|October 4, 2011
Safety review: dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumorsWilliam H Ludlam, Lowell Anthony
Case Reports in Endocrinology|December 28, 2016
Patients with Acromegaly Presenting with Colon Cancer: A Case SeriesMurray B Gordon, Samer Nakhle, William H Ludlam
Current Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Second-line treatment for Cushing's disease when initial pituitary surgery is unsuccessfulMaria Fleseriu, D Lynn Loriaux, William H Ludlam
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 6, 2015
HISTORICAL RESPONSE RATES OF SOMATOSTATIN ANALOGUES IN THE TREATMENT OF ACROMEGALY: A SYSTEMATIC REVIEWMichael H Shanik, Paul D Cao, William H Ludlam
Neurosurgical Focus|October 27, 2007
Cyclic Cushing syndrome: definitions and treatment implicationsDennis A Velez, Marc R Mayberg, William H Ludlam
Pituitary|December 16, 2015
Algorithm development and the clinical and economic burden of Cushing's disease in a large US health plan databaseTanya Burton, Elisabeth Le Nestour, Maureen Neary, et al.
Pituitary|January 22, 2016
Incidence and prevalence of acromegaly in a large US health plan databaseTanya Burton, Elisabeth Le Nestour, Maureen Neary, et al.
Pituitary|April 6, 2015
Incremental healthcare resource utilization and costs in US patients with Cushing's disease compared with diabetes mellitus and population controlsMichael S Broder, Maureen P Neary, Eunice Chang, et al.
Expert Review of Endocrinology & Metabolism|February 21, 2019
Pasireotide (SOM230): a novel pituitary-targeted medical therapy for the treatment of patients with Cushing's diseaseKelley J Moloney, Jennifer U Mercado, William H Ludlam, et al.
Clinical Case Reports|December 17, 2016
Diagnosis of Cushing's disease in a patient with consistently normal urinary free cortisol levels: a case reportKelley J Moloney, Jennifer U Mercado, William H Ludlam, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Advances in Therapy|October 4, 2011
Safety review: dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumorsWilliam H Ludlam, Lowell Anthony
Case Reports in Endocrinology|December 28, 2016
Patients with Acromegaly Presenting with Colon Cancer: A Case SeriesMurray B Gordon, Samer Nakhle, William H Ludlam
Current Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Second-line treatment for Cushing's disease when initial pituitary surgery is unsuccessfulMaria Fleseriu, D Lynn Loriaux, William H Ludlam
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 6, 2015
HISTORICAL RESPONSE RATES OF SOMATOSTATIN ANALOGUES IN THE TREATMENT OF ACROMEGALY: A SYSTEMATIC REVIEWMichael H Shanik, Paul D Cao, William H Ludlam
Neurosurgical Focus|October 27, 2007
Cyclic Cushing syndrome: definitions and treatment implicationsDennis A Velez, Marc R Mayberg, William H Ludlam
Pituitary|December 16, 2015
Algorithm development and the clinical and economic burden of Cushing's disease in a large US health plan databaseTanya Burton, Elisabeth Le Nestour, Maureen Neary, et al.
Pituitary|January 22, 2016
Incidence and prevalence of acromegaly in a large US health plan databaseTanya Burton, Elisabeth Le Nestour, Maureen Neary, et al.
Pituitary|April 6, 2015
Incremental healthcare resource utilization and costs in US patients with Cushing's disease compared with diabetes mellitus and population controlsMichael S Broder, Maureen P Neary, Eunice Chang, et al.
Expert Review of Endocrinology & Metabolism|February 21, 2019
Pasireotide (SOM230): a novel pituitary-targeted medical therapy for the treatment of patients with Cushing's diseaseKelley J Moloney, Jennifer U Mercado, William H Ludlam, et al.
Clinical Case Reports|December 17, 2016
Diagnosis of Cushing's disease in a patient with consistently normal urinary free cortisol levels: a case reportKelley J Moloney, Jennifer U Mercado, William H Ludlam, et al.
Pageof 3